Photodiagnosis and Photodynamic Therapy
Volume 7, Issue 2 , Pages 106-114 , June 2010

Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate

  • Zhengwen Xiao

      Affiliations

    • Departments of Oncology and Surgery, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Richard J. Owen

      Affiliations

    • Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Weiyang Liu

      Affiliations

    • Department of Electric and Computer Engineering, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • John Tulip

      Affiliations

    • Department of Electric and Computer Engineering, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Kevin Brown

      Affiliations

    • QuestPharmaTech, Inc., Edmonton, Alberta, Canada
    • ,
  • Thomas Woo

      Affiliations

    • QuestPharmaTech, Inc., Edmonton, Alberta, Canada
    • ,
  • Ronald B. Moore, MD, PhD

      Affiliations

    • Departments of Oncology and Surgery, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationCorresponding author at: Department of Surgery, University of Alberta, 2D2 Walter Mackenzie Health Sciences Centre, 8440-112 Street, Edmonton, Alberta, T6G 2B7, Canada. Tel.: +1 780 407 6330/432 8325; fax: +1 780 407 6331/432 8333.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  2. Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Management of complications of prostate cancer treatment. CA Cancer J Clin. 2008;58:196–213
  3. Xiao Z, Dickey D, Owen RJ, Tulip J, Moore RB. Interstitial photodynamic therapy of the canine prostate using intra-arterial administration of photosensitizer and computerized pulsed light delivery. J Urol. 2007;178:308–313
  4. Nathan TR, Whitelaw BE, Chang SC, et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol. 2002;168:1427–1432
  5. Trachtenberg J, Weersink RA, Davidson SRH, et al. Vascular-targeted photodynamic therapy (padoporfin WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU Int. 2008;102:556–562
  6. Moore RB, Xiao Z, Owen RJ, et al. Photodynamic therapy of the canine prostate: intra-arterial drug delivery. Cardiovasc Intervent Radiol. 2008;31:164–176
  7. Xiao Z, Halls S, Dickey D, Tulip J, Moore RB. Fractionated versus standard continuous light delivery in interstitial photodynamic therapy of Dunning prostate carcinomas. Clin Cancer Res. 2007;13:7496–7505
  8. Paul BT, Babu MS, Santhoshkumar TR, et al. Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents. J Photochem Photobiol B Biol. 2009;94:38–44
  9. Allison RR, Mota HC, Sibata CH. Clinical PD/PDT in North America: an historical review. Photodiagn Photodyn Ther. 2004;1:263–277
  10. Selman SH, Albrecht D, Keck RW, Brennan P, Kondo S. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate. J Urol. 2001;1795–1801
  11. Chang S, Buonaccorsi G, MacRobert A, Bown SG. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra (hydroxyphenyl) chlorine. Int J Cancer. 1996;67:555–562
  12. Chen B, Pogue BW, Hasan T. Liposomal delivery of photosensitizing agents. Expert Opin Drug Deliv. 2005;2:477–487
  13. Hogg JC, Ho Coxson, Brumwell ML, et al. Erythrocyte and polymorphonuclear cell transit time and concentration in human pulmonary capillaries. J Appl Physiol. 1994;4:1795–1800
  14. Liu D, Mori A, Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta. 1992;1104:95–101
  15. Liu D, Mori A, Huang L. Large liposomes containing ganglioside GM1 accumulate effectively in spleen. Biochim Biophys Acta. 1991;1066:159–165
  16. Rastinehad AR, Caplin DM, Ost MC, et al. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology. 2008;71(2):181–184
  17. Park YH, Lee JH, Kim HH. Severe bleeding after laparascopic radical prostatectomy: successful management with transarterial embolization. J Endourol. 2008;22(12):2687–2689
  18. Carnevale FC, Antunes AA, da Motta Leal Filho JM. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010;33(2):355–361

PII: S1572-1000(10)00034-7

doi: 10.1016/j.pdpdt.2010.03.003

Photodiagnosis and Photodynamic Therapy
Volume 7, Issue 2 , Pages 106-114 , June 2010

Article Tools

* Image Usage & Resolution